BioMarin Pharmaceutical Inc (BMRN) stock
BMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30104% above fair value
$61.42−0.01 (-0.02%)
Close on Nov 19, 2026Market cap $11.89BP/E 161.6Yield –
BioMarin Pharmaceutical shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
BioMarin Pharmaceutical's shares outstanding was 194M at Jun 30, 2026. For fiscal 2025 it was 197M, up 0.3% from the year before. Over ten years it grew 2.1% a year on average. The highest annual figure on record is 197M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 197M | +0.3% |
| FY2024 | Dec 31, 2024 | 197M | +2.7% |
| FY2023 | Dec 31, 2023 | 192M | +1.4% |
| FY2022 | Dec 31, 2022 | 189M | +3.3% |
| FY2021 | Dec 31, 2021 | 183M | -4.6% |
| FY2020 | Dec 31, 2020 | 192M | +7.1% |
| FY2019 | Dec 31, 2019 | 179M | +1.0% |
| FY2018 | Dec 31, 2018 | 177M | +1.6% |
| FY2017 | Dec 31, 2017 | 174M | +4.9% |
| FY2016 | Dec 31, 2016 | 166M | +3.9% |
| FY2015 | Dec 31, 2015 | 160M | +9.3% |
| FY2014 | Dec 31, 2014 | 146M | +6.2% |
| FY2013 | Dec 31, 2013 | 138M | +14.5% |
| FY2012 | Dec 31, 2012 | 120M | +7.3% |
| FY2011 | Dec 31, 2011 | 112M | -10.8% |
| FY2010 | Dec 31, 2010 | 126M | +25.3% |
| FY2009 | Dec 31, 2009 | 100M | -3.2% |
| FY2008 | Dec 31, 2008 | 104M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 194M | -1.3% |
| Q1 FY2026 | Mar 31, 2026 | 198M | +0.6% |
| Q4 FY2025 | Dec 31, 2025 | 199M | +1.1% |
| Q3 FY2025 | Sep 30, 2025 | 192M | -2.6% |
| Q2 FY2025 | Jun 30, 2025 | 197M | -1.7% |
| Q1 FY2025 | Mar 31, 2025 | 196M | -1.4% |
| Q4 FY2024 | Dec 31, 2024 | 197M | +8.6% |
| Q3 FY2024 | Sep 30, 2024 | 197M | +3.1% |
| Q2 FY2024 | Jun 30, 2024 | 201M | +2.8% |
| Q1 FY2024 | Mar 31, 2024 | 199M | +2.5% |
| Q4 FY2023 | Dec 31, 2023 | 181M | +1.2% |
| Q3 FY2023 | Sep 30, 2023 | 191M | +3.0% |
| Q2 FY2023 | Jun 30, 2023 | 195M | +4.0% |
| Q1 FY2023 | Mar 31, 2023 | 194M | -0.3% |
| Q4 FY2022 | Dec 31, 2022 | 179M | -2.4% |
| Q3 FY2022 | Sep 30, 2022 | 186M | +1.3% |
| Q2 FY2022 | Jun 30, 2022 | 187M | +1.1% |
| Q1 FY2022 | Mar 31, 2022 | 195M | +5.7% |
| Q4 FY2021 | Dec 31, 2021 | 184M | +0.9% |
| Q3 FY2021 | Sep 30, 2021 | 183M | -7.3% |
| Q2 FY2021 | Jun 30, 2021 | 185M | +2.6% |
| Q1 FY2021 | Mar 31, 2021 | 184M | -1.5% |
| Q4 FY2020 | Dec 31, 2020 | 182M | +1.3% |
| Q3 FY2020 | Sep 30, 2020 | 198M | +6.3% |
| Q2 FY2020 | Jun 30, 2020 | 181M | +0.9% |
| Q1 FY2020 | Mar 31, 2020 | 187M | +5.0% |
| Q4 FY2019 | Dec 31, 2019 | 180M | +0.4% |
| Q3 FY2019 | Sep 30, 2019 | 186M | +4.8% |
| Q2 FY2019 | Jun 30, 2019 | 179M | +1.2% |
| Q1 FY2019 | Mar 31, 2019 | 178M | +1.2% |
| Q4 FY2018 | Dec 31, 2018 | 179M | +1.9% |
| Q3 FY2018 | Sep 30, 2018 | 177M | +1.4% |
| Q2 FY2018 | Jun 30, 2018 | 177M | +1.4% |
| Q1 FY2018 | Mar 31, 2018 | 176M | +2.0% |
| Q4 FY2017 | Dec 31, 2017 | 175M | +1.9% |
| Q3 FY2017 | Sep 30, 2017 | 175M | +4.4% |
| Q2 FY2017 | Jun 30, 2017 | 174M | – |
| Q1 FY2017 | Mar 31, 2017 | 173M | – |
| Q4 FY2016 | Dec 31, 2016 | 172M | – |
| Q3 FY2016 | Sep 30, 2016 | 168M | – |
See a number that looks wrong?